274
Views
34
CrossRef citations to date
0
Altmetric
Review

Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy

&
Pages 3147-3161 | Published online: 24 Sep 2018

References

  • RobisonRThe Possible Significance of Hexosephosphoric Esters in OssificationBiochem J192317228629316743183
  • SillerAFWhyteMPAlkaline Phosphatase: Discovery and Naming of Our Favorite EnzymeJ Bone Miner Res201833236236428727174
  • MillánJLWhyteMPAlkaline Phosphatase and HypophosphatasiaCalcif Tissue Int201698439841626590809
  • MillánJLMammalian Alkaline Phosphatases: From Biology to Applications in Medicine and BiotechnologyWeinheim, GermanyWiley-VCH2006
  • MeyerJLFleischHCalcification inhibitors in rat and human serum and plasmaBiochim Biophys Acta198479921151216329313
  • MeyerJLCan biological calcification occur in the presence of pyro-phosphate?Arch Biochem Biophys19842311186326671
  • BisazSRussellRGFleischHIsolation of inorganic pyrophosphate from bovine and human teethArch Oral Biol19681366836964299510
  • FleischHRussellRGStraumannFEffect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasisNature196621250659019034306793
  • FleischHSchiblerDMaerkiJFrossardIInhibition of aortic calcification by means of pyrophosphate and polyphosphatesNature1965207500313001301
  • FleischHBisazSIsolation from urine of pyrophosphate, a calcification inhibitorAm J Physiol1962203467167513945462
  • FleischHBisazSMechanism of calcification: inhibitory role of pyrophosphateNature19621954844911
  • GurleyKAChenHGuentherCMineral formation in joints caused by complete or joint-specific loss of ANK functionJ Bone Miner Res20062181238124716869722
  • MurshedMHarmeyDMillanJLMckeeMDKarsentyGUnique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to boneGenes Dev20051991093110415833911
  • HarmeyDHessleLNarisawaSJohnsonKATerkeltaubRMillanJLConcerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disordersAm J Pathol200416441199120915039209
  • RutschFRufNVaingankarSMutations in ENPP1 are associated with ‘idiopathic’ infantile arterial calcificationNat Genet200334437938112881724
  • NocitiFHBerryJEFosterBLCementum: a phosphate-sensitive tissueJ Dent Res2002811281782112454094
  • TerkeltaubRAInorganic pyrophosphate generation and disposition in pathophysiologyAm J Physiol Cell Physiol20012811C1C1111401820
  • RutschFVaingankarSJohnsonKPC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcificationAm J Pathol2001158254355411159191
  • JohnsonKAHessleLVaingankarSOsteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1Am J Physiol Regul Integr Comp Physiol20002794R1365R137711004006
  • HoAMJohnsonMDKingsleyDMRole of the mouse ank gene in control of tissue calcification and arthritisScience2000289547726527010894769
  • FosterBLNagatomoKJNocitiFHCentral role of pyro-phosphate in acellular cementum formationPLoS One201276e3839322675556
  • MillánJLThe role of phosphatases in the initiation of skeletal mineralizationCalcif Tissue Int201393429930623183786
  • ZweiflerLEPatelMKNocitiFHCounter-regulatory phosphatases TNAP and NPP1 temporally regulate tooth root cementogenesisInt J Oral Sci201571274125504209
  • MornetEHypophosphatasiaMetabolism20188214215528939177
  • WhyteMPHypophosphatasia – aetiology, nosology, pathogenesis, diagnosis and treatmentNat Rev Endocrinol201612423324626893260
  • ThakkerRVWhyteMPEismanJIgarashiTGenetics of Bone Biology and Skeletal DiseaseLondonAcademic Press2017
  • MornetEGenetics of hypophosphatasiaArchives de Pédiatrie2017245S551S555
  • WhyteMPCoburnSPRyanLMEricsonKLZhangFHypophosphatasia: Biochemical hallmarks validate the expanded pediatric clinical nosologyBone20181109610629360619
  • WenkertDMcalisterWHCoburnSPHypophosphatasia: nonlethal disease despite skeletal presentation in utero (17 new cases and literature review)J Bone Miner Res201126102389239821713987
  • SeshiaSSDerbyshireGHaworthJCHoogstratenJMyopathy with hypophosphatasiaArch Dis Child19906511301312301976
  • CollmannHMornetEGattenlöhnerSBeckCGirschickHNeurosurgical aspects of childhood hypophosphatasiaChilds Nerv Syst200925221722318769927
  • WhyteMPZhangFWenkertDHypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patientsBone20157522923925731960
  • GirschickHJMornetEBeerMWarmuth-MetzMSchneiderPChronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancyBMC Pediatr200771317241478
  • WhyteMPWenkertDMcalisterWHChronic recurrent multi-focal osteomyelitis mimicked in childhood hypophosphatasiaJ Bone Miner Res20092481493150519335222
  • Kosnik-InfingerLGendronCGordonCBPanBSvan AalstJAVogelTWEnzyme replacement therapy for congenital hypophosphatasia allows for surgical treatment of related complex craniosynostosis: a case seriesNeurosurg Focus2015385E10
  • BerksethKETebbenPJDrakeMTHefferanTEJewisonDEWermersRAClinical spectrum of hypophosphatasia diagnosed in adultsBone2013541212723352924
  • GenestFSeefriedLSubtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at allOsteoporos Int20182981815182529774402
  • RodriguesTRGeorgettiAPMartinsLPereira NetoJSFosterBLNocitiFHJrClinical correlate: case study of identical twins with cementum and periodontal defects resulting from odontohypophosphatasiaMcCauleyLKSomermanMJMineralized Tissues in Oral and Craniofacial Science: Biological Principles and Clinical Correlates1st edAmes, IAWiley-Blackwell2012
  • ReibelAManièreMCClaussFOrodental phenotype and genotype findings in all subtypes of hypophosphatasiaOrphanet J Rare Dis200941619232125
  • FosterBLNocitiFHSomermanMJThe rachitic toothEndocr Rev201435113423939820
  • FosterBLRamnitzMSGafniRIRare bone diseases and their dental, oral, and craniofacial manifestationsJ Dent Res2014937 Suppl7S19S24700690
  • Bloch-ZupanAHypophosphatasia: diagnosis and clinical signs – a dental surgeon perspectiveInt J Paediatr Dent201626642643827030892
  • MoriMDearmeySLWeberTJKishnaniPSCase series: Odon-tohypophosphatasia or missed diagnosis of childhood/adult-onset hypophosphatasia? – Call for a long-term follow-up of premature loss of primary teethBone Rep2016522823228580391
  • ValletMRalstonSHBiology and Treatment of Paget’s Disease of BoneJ Cell Biochem2016117228929926212817
  • WhyteMPMcalisterWHPattonLSEnzyme replacement therapy for infantile hypophosphatasia attempted by intravenous infusions of alkaline phosphatase-rich Paget plasma: Results in three additional patientsJ Pediatr198410569269336502342
  • WhyteMPValdesRRyanLMMcalisterWHInfantile hypophosphatasia: Enzyme replacement therapy by intravenous infusion of alkaline phosphatase-rich plasma from patients with Paget bone diseaseJ Pediatr198210133793867108657
  • WhyteMPMagillHLFallonMDHerrodHGInfantile hypophosphatasia: normalization of circulating bone alkaline phosphatase activity followed by skeletal remineralization. Evidence for an intact structural gene for tissue nonspecific alkaline phosphataseJ Pediatr1986108182883944698
  • WhyteMPKurtzbergJMcalisterWHMarrow cell transplantation for infantile hypophosphatasiaJ Bone Miner Res200318462463612674323
  • CahillRAWenkertDPerlmanSAInfantile hypophosphatasia: transplantation therapy trial using bone fragments and cultured osteoblastsThe Journal of Clinical Endocrinology & Metabolism20079282923293017519318
  • TadokoroMKanaiRTaketaniTUchioYYamaguchiSOhgushiHNew bone formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasiaJ Pediatr2009154692493019446101
  • TaketaniTOyamaCMiharaAEx Vivo Expanded Allogeneic Mesenchymal Stem Cells with Bone Marrow Transplantation Improved Osteogenesis in Infants with Severe HypophosphatasiaCell Transplant201524101931194325396326
  • DeebAABruceSNMorrisAACheethamTDInfantile hypophosphatasia: disappointing results of treatmentActa Paediatr200089673074310914973
  • CundyTMichigamiTTachikawaKReversible Deterioration in Hypophosphatasia Caused by Renal Failure With Bisphosphonate TreatmentJ Bone Miner Res20153091726173725736332
  • RighettiMWachJDesmarchelierRCouryFTeriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fracturesJoint Bone Spine201885336536729246529
  • DoshiKBHamrahianAHLicataAATeriparatide treatment in adult hypophosphatasia in a patient exposed to bisphosphonate: a case reportClin Cases Miner Bone Metab20096326626922461258
  • SuttonRAMummSCoburnSPEricsonKLWhyteMP“Atypical femoral fractures” during bisphosphonate exposure in adult hypophosphatasiaJ Bone Miner Res201227598799422322541
  • WhyteMPMummSDealCAdult hypophosphatasia treated with teriparatideJ Clin Endocrinol Metab20079241203120817213282
  • NarisawaSFröhlanderNMillánJLInactivation of two mouse alkaline phosphatase genes and establishment of a model of infantile hypophosphatasiaDev Dyn199720834324469056646
  • FeddeKNBlairLSilversteinJAlkaline phosphatase knockout mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasiaJ Bone Miner Res199914122015202610620060
  • ShaoJ-SEngleMXieQEffect of tissue non-specific alkaline phosphatase in maintenance of structure of murine colon and stomachMicrosc Res Tech200051212112811054862
  • WennbergCHessleLLundbergPFunctional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout miceJ Bone Miner Res200015101879188811028439
  • NarisawaSWennbergCLuis MillánJMillanJLAbnormal vitamin B6 metabolism in alkaline phosphatase knock-out mice causes multiple abnormalities, but not the impaired bone mineralizationJ Pathol2001193112513311169525
  • HessleLJohnsonKAAndersonHCTissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralizationProc Natl Acad Sci U S A200299149445944912082181
  • NarisawaSHuangLIwasakiAHasegawaHAlpersDHMillánJLAccelerated fat absorption in intestinal alkaline phosphatase knockout miceMol Cell Biol200323217525753014560000
  • AndersonHCSipeJBHessleLImpaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient miceAm J Pathol2004164384184714982838
  • AndersonHCHarmeyDCamachoNPSustained osteomalacia of long bones despite major improvement in other hypophosphatasia-related mineral deficits in tissue nonspecific alkaline phosphatase/nucleotide pyrophosphatase phosphodiesterase 1 double-deficient miceAm J Pathol200516661711172015920156
  • HarmeyDJohnsonKAZelkenJElevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(−/−) miceJ Bone Miner Res20062191377138616939396
  • BeertsenWVandenbosTEvertsVRoot development in mice lacking functional tissue non-specific alkaline phosphatase gene: inhibition of acellular cementum formationJ Dent Res19997861221122910371245
  • YadavMCde OliveiraRCFosterBLEnzyme replacement prevents enamel defects in hypophosphatasia miceJ Bone Miner Res20122781722173422461224
  • FosterBLNagatomoKJTsoHWTooth root dentin mineralization defects in a mouse model of hypophosphatasiaJ Bone Miner Res201328227128222991301
  • LiuJNamHKCampbellCGasqueKCMillánJLHatchNETissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(−/−) mouse model of infantile hypophosphatasiaBone201467819425014884
  • NamHKSharmaMLiuJHatchNETissue Nonspecific Alkaline Phosphatase (TNAP) Regulates Cranial Base Growth and Synchondrosis MaturationFront Physiol2017816128377728
  • DurusselJLiuJCampbellCNamHKHatchNEBone mineralization-dependent craniosynostosis and craniofacial shape abnormalities in the mouse model of infantile hypophosphatasiaDev Dyn2016245217518226605996
  • CamposMCoutureCHirataIYHuman recombinant endopeptidase PHEX has a strict S1’ specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoproteinBiochem J2003373127127912678920
  • BoileauGTenenhouseHSDesgroseillersLCrinePCharacterization of PHEX endopeptidase catalytic activity: identification of parathyroid-hormone-related peptide 107–139 as a substrate and osteocalcin, PPi and phosphate as inhibitorsBiochem J2001355370771311311133
  • MillánJLNarisawaSLemireIEnzyme replacement therapy for murine hypophosphatasiaJ Bone Miner Res200823677778718086009
  • NishiokaTTomatsuSGutierrezMAEnhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptideMol Genet Metab200688324425516616566
  • FisherLWFedarkoNSSix genes expressed in bones and teeth encode the current members of the SIBLING family of proteinsConnect Tissue Res2003441334012952171
  • YadavMCLemireILeonardPDose response of bone-targeted enzyme replacement for murine hypophosphatasiaBone201149225025621458605
  • LiuJCampbellCNamHKEnzyme replacement for craniofacial skeletal defects and craniosynostosis in murine hypophosphatasiaBone20157820321125959417
  • MckeeMDNakanoYMasicaDLEnzyme replacement therapy prevents dental defects in a model of hypophosphatasiaJ Dent Res201190447047621212313
  • Davit-BéalTGabayJAntoniolliPMasle-FarquharJWolikowMDental complications of rickets in early childhood: case report on 2 young girlsPediatrics20141334e1077e108124616355
  • Biosse DuplanMCoyacBRBardetCPhosphate and Vitamin D Prevent Periodontitis in X-Linked HypophosphatemiaJ Dent Res201796438839527821544
  • FosterBLHujoelPPVitamin D in dentoalveolar and oral healthFeldmanDPikeJWBouillonRVitamin D1Fourth editionLondon, UKAcademic Press2018497520
  • WhyteMPGreenbergCRSalmanNJEnzyme-replacement therapy in life-threatening hypophosphatasiaN Engl J Med20123661090491322397652
  • WhyteMPRockman-GreenbergCOzonoKAsfotase alfa treatment improves survival for perinatal and infantile hypophosphatasiaThe Journal of Clinical Endocrinology & Metabolism2016101133434226529632
  • KitaokaTTajimaTNagasakiKSafety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: Results from a Japanese clinical trialClin Endocrinol20178711019
  • KishnaniPSRockman-GreenbergCDenkerAEMoseleySWhyteMPBiochemical and physical function outcomes after 5 years of treatment with asfotase Alfa in adolescents and adults with hypophosphatasia: Phase 2 study resultsInternational Conference on Children’s Bone Health2017 Available from: http://www.bone-abstracts.org/ba/0006/ba0006OC25.htmLast accessed September 6, 2018
  • OkazakiYKitajimaHMochizukiNKitaokaTMichigamiTOzonoKLethal hypophosphatasia successfully treated with enzyme replacement from day 1 after birthEur J Pediatr2016175343343726459154
  • RemdeHCooperMSQuinklerMSuccessful Asfotase Alfa Treatment in an Adult Dialysis Patient with Childhood-Onset HypophosphatasiaJ Endocr Soc2017191188119329264574
  • CostainGMooreAMMunroeLEnzyme replacement therapy in perinatal hypophosphatasia: Case report of a negative outcome and lessons for clinical practiceMol Genet Metab Rep201814222629159075
  • VidmarAPNgCGansterAPitukcheewanontPAsfotase alfa treatment of an African-American infant with perinatal hypophosphatasia and homozygous hemoglobin SC diseaseIBMS BoneKEy201714849
  • BowdenSAAdlerBHAsfotase alfa treatment for 1year in a 16year-old male with severe childhood hypophosphatasiaOsteoporos Int201829251151529046930
  • BowdenSAAdlerBHReappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasiaOsteporos Int201829921552156
  • KlidarasPSevertJAggersDPayneJMillerPDIngSWFracture healing in two adult patients with hypophosphatasia after asfotase alfa therapyJBMR Plus2018984
  • WhyteMPMadsonKLPhillipsDAsfotase alfa therapy for children with hypophosphatasiaJCI Insight201619e8597127699270
  • KishnaniPSMadsonKLWhyteMPGayronMFujitaKRock-man-GreenbergCBiochemical and physical function outcomes in adolescents and adults with hypophosphatasia treated with asfotase alfa for up to 4 years: interim results from a phase II studyMetabolic and Genetic Bone Disorders. Endocrine Society2016OR26-23
  • TomazosICMoseleySL’ItalienGda SilvaHGPhillipsDImprovements in the 6-minute walk test and correlation with quality-of-life measures in children and adults with hypophosphatasia treated with asfotase alfaENDO 20172017Orlando, FL, USA Available from: https://www.endocrine.org/meetings/endo-annual-meetings/abstract-details?ID=29927Last accessed September 6, 2018
  • KishnaniPSRushETArundelPMonitoring guidance for patients with hypophosphatasia treated with asfotase alfaMol Genet Metab20171221–241728888853
  • GirschickHJSchneiderPHaubitzIEffective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasiaOrphanet J Rare Dis2006112416803637
  • BeckCMorbachHRichlPStenzelMGirschickHJHow can calcium pyrophosphate crystals induce inflammation in hypophosphatasia or chronic inflammatory joint diseases?Rheumatol Int200929322923818821074
  • PoryoMMeyerSEymannRYilmazUNematSRohrerTClinical Images: A Cloudy Skull-Hypophosphatasia as Reason for Copper-Beaten SkullNeuropediatrics201647641027780282
  • YamamotoSOrimoHMatsumotoTProlonged survival and phenotypic correction of Akp2(−/−) hypophosphatasia mice by lentiviral gene therapyJ Bone Miner Res201126113514220687159
  • MatsumotoTMiyakeKYamamotoSRescue of severe infantile hypophosphatasia mice by AAV-mediated sustained expression of soluble alkaline phosphataseHum Gene Ther201122111355136421388343
  • SuganoHMatsumotoTMiyakeKSuccessful gene therapy in utero for lethal murine hypophosphatasiaHum Gene Ther201223439940622133046
  • Nakamura-TakahashiAMiyakeKWatanabeATreatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vectorMol Ther Methods Clin Dev201631505926904710
  • IijimaOMiyakeKWatanabeAPrevention of Lethal Murine Hypophosphatasia by Neonatal Ex Vivo Gene Therapy Using Lentivi-rally Transduced Bone Marrow CellsHum Gene Ther2015261280181226467745
  • Kiffer-MoreiraTSheenCRGasqueKCCatalytic signature of a heat-stable, chimeric human alkaline phosphatase with therapeutic potentialPLoS One201492e8937424586729
  • GasqueKCFosterBLKussPImprovement of the skeletal and dental hypophosphatasia phenotype in Alpl−/− mice by administration of soluble (non-targeted) chimeric alkaline phosphataseBone20157213714725433339
  • SeefriedLBaumannJHemsleySEfficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasiaJ Clin Invest201712762148215828436937
  • ShapiroJRLewieckiEMHypophosphatasia in adults: clinical assessment and treatment considerationsJ Bone Miner Res201732101977198028731215
  • WhyteMPHypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New ChallengesJ Bone Miner Res201732466767528084648